Variants of the melanocortin-1 receptor: do they matter clinically?
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanisms and clinical associations with no primary data or systematic methodology.
PubMed 25219681 · doi:10.1111/exd.12540
What was done
This narrative review summarizes the biological functions and clinical implications of melanocortin 1 receptor (MC1R) single nucleotide polymorphisms. It examines mechanisms linking MC1R variants to fair skin phenotypes, UV-induced skin carcinogenesis (melanoma and keratinocyte cancers), evolutionary factors like vitamin D synthesis, and emerging therapeutic applications of MC1R agonists.
What was found
The abstract reports no numerical values, effect sizes, or confidence intervals. It describes qualitative associations showing that loss-of-function MC1R variants impair UV photoprotection via pigmentary and non-pigmentary pathways (reduced DNA repair, altered cell proliferation, and possible immune effects), and notes preliminary evidence that the MC1R agonist [Nle4-D-Phe7]-alpha-MSH combined with UVB promotes repigmentation in vitiligo.
Why it matters
It highlights that MC1R variants drive skin carcinogenesis through non-pigmentary DNA repair pathways as well as pigmentary mechanisms, identifying MC1R agonists as candidate targets for photoprotection and pigmentary disorders.
Limits
The abstract provides no primary data, sample sizes, or quantitative risk estimates. As a narrative review, it lacks a systematic literature search, standardized study selection, and formal bias assessment.
Cited by
- supports Melanin absorbs energy to protect skin DNA from sun damage, and genetic variants associated with red hair evolved in northern latitudes to allow people to synthesize vitamin D by reducing melanin-mediated UV blockage.